Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: Successful in utero treatment with levothyroxine

Thyroid

Volumn 21, Issue 1, 2011, Pages 75-81

  Bliddal, Sofie ^a   Rasmussen, Åse Krogh ^a   Sundberg, Karin ^a   Brocks, Vibeke ^a   Skovbo, Peter ^b   Feldt Rasmussen, Ulla ^a  

^a Copenhagen University ^*  (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORDOCENTESIS; DRUG DOSE REDUCTION; EUTHYROIDISM; FEMALE; FETUS; FETUS BLOOD; FETUS DISEASE; FETUS ECHOGRAPHY; GOITER; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADULT; ANTITHYROID AGENTS; FEMALE; FETAL DISEASES; GOITER; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; INFANT, NEWBORN; MALE; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; PROPYLTHIOURACIL; THYROTROPIN; THYROXINE;

EID: 78651266006     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0286     Document Type: Article

References (45)

1. Gallagher MP, Schachner HC, Levine LS, Fisher DA, Berdon WE, Oberfield SE 2001 Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves' disease during pregnancy: a problem revisited. J Pediatr 139: 896-900.
2. Cohen O, Pinhas-Hamiel O, Sivan E, Dolitski M, Lipitz S, Achiron R 2003 Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy. Prenat Diagn 23:740-742.
3. Burrow GN 1965 Neonatal goiter after maternal pro-pylthiouracil therapy. J Clin Endocrinol Metab 25:403-408.
4. LaFranchi SH, Haddow JE, Hollowell JG 2005 Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? Thyroid 15:60-71.
5. Burman KD 2009 Controversies surrounding pregnancy, maternal thyroid status, and fetal outcome. Thyroid 19: 323-326.
6. Hashimoto H, Hashimoto K, Suehara N 2006 Successful in utero treatment of fetal goitrous hypothyroidism: case report and review of the literature. Fetal Diagn Ther 21:360-365.
7. Gruner C, Kollert A, Wildt L, Dorr HG, Beinder E, Lang N 2001 Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature. Fetal Diagn Ther 16:47-51.
8. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A 2007 Management of thyroid dysfunction during pregnancy and post-partum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92:S1-S47.
9. Milham S Jr. 1985 Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy. Teratology 32:321.
10. Di GE, Schaefer C, Mastroiacovo PP, Cournot MP, Bene-dicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J, Clementi M 2001 Adverse effects of prenatal methimazole exposure. Teratology 64:262-266.
11. Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E, Urioste M 1992 Methimazole in animal feed and congenital aplasia cutis. Lancet 339:742-743.
12. Clementi M, Di GE, Cassina M, Leoncini E, Botto LD, Mastroiacovo P 2010 Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 95: E337-E341.
13. FDA. Information for HealthcareProfessionals-Propylthiou-racil-Induced Liver Failure. Available at: www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationfor PatientsandProviders/ DrugSafetyInformationforHeathcare Professionals/ucm162701.htm. Accessed October 4, 2010.
14. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross D, Sosa JA, Stan MN 2009 The role of propylthiouracil in the management of graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19: 673-674.
15. Cooper DS, Rivkees SA 2009 Putting propylthiouracil in perspective. J Clin Endocrinol Metab 94:1881-1882.
16. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O 1992 Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol 80:359-364.
17. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH 1994 Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84:946-949.
18. Dallas JS 2003 Autoimmune thyroid disease and pregnancy: relevance for the child. Autoimmunity 36:339-350.
19. Glinoer D 2003 Management of hypo-and hyperthyroidism during pregnancy. Growth Horm IGF Res 13 Suppl A: S45-S54.
20. Glinoer D 1998 Thyroid hyperfunction during pregnancy. Thyroid 8:859-864.
21. Raymond J, LaFranchi SH 2010 Fetal and neonatal thyroid function: review and summary of significant new findings. Curr Opin Endocrinol Diabetes Obes 17:1-7.
22. Gardner DF, Cruikshank DP, Hays PM, Cooper DS 1986 Pharmacology of propylthiouracil (PTU) in pregnant hy-perthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 62:217-220.
23. Brent GA 1997 Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol 40:3-15.
24. Feldt-Rasmussen U 2008 Which thyroid function tests should we be measuring during gestation? In: Lazarus J, Pirags V, Butz S (eds) The Thyroid and Reproduction. Merck European Thyroid Symposium Riga 2008, May 22-25. Georg Thieme Verlag, Stuttgart, pp 77-83.
25. Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J, McGregor AM 1991 Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 324:532-536.
26. Seeds JW 2004 Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol 191:607-615.
27. Luton D, Le G, I, Vuillard E, Castanet M, Guibourdenche J, Noel M, Toubert M-E, Leger J, Boissinot C, Schlageter M-H, Garel C, Tebeka B, Oury J-F, Czernichow P, Polak M 2005 Management of Graves' disease during pregnancy: The key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 90:6093-6098.
28. Glinoer D, Riahi M, Grun J-P, Kinthaert J 1994 Risk of sub-clinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 79:197-204.
29. Momotani N, Ito K 1991 Treatment of pregnant patients with Basedow's disease. Exp Clin Endocrinol 97:268-274.
30. Smyth PP, Wijeyaratne CN, Kaluarachi WN, Smith DF, Premawardhana LD, Parkes AB, Jayasinghe A, de Silva DG, Lazarus JH 2005 Sequential studies on thyroid antibodies during pregnancy. Thyroid 15:474-477.
31. Wang R, Nelson JC, Weiss RM, Wilcox RB 2000 Accuracy of free thyroxine measurements across natural ranges of thy-roxine binding to serum proteins. Thyroid 10:31-39.
32. Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J 2007 Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 17:303-311. (Pubitemid 46776133)
33. Baloch Z, Carayon P, Conte-Devolx B, et al. 2002 NACB: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. National Academy of Clinical Biochemistry, Washington, DC.
34. Dashe JS, Casey BM, Wells CE, McIntire DD, Byrd EW, Leveno KJ, Cunningham FG 2005 Thyroid-stimulating hormone in singleton and twin pregnancy: importance of ges-tational age-specific reference ranges. Obstet Gynecol 106: 753-757.
35. Springer D, Zima T, Limanova Z 2009 Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 160:791-797.
36. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, Bilous R 2007 Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 92:203-207.
37. Boas M, Forman JL, Juul A, Feldt-Rasmussen U, Skakkebaek NE, Hilsted L, Chellakooty M, Larsen T, Larsen JF, Petersen JH, Main KM 2009 Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women. Eur J Endocrinol 161:903-910.
38. Haddow JE, Knight GJ, Palomaki GE, McClain MR, Pulk-kinen AJ 2004 The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen 11:170-174.
39. Lambert-Messerlian G, McClain M, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME 2008 First-and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First-and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol 199:e1-e6.
40. Glinoer D, Spencer CA 2010 Serum TSH determinations in pregnancy: how, when and why? Nat Rev Endocrinol 6:526-529.
41. Lassen PD, Sundberg K, Juul A, Skibsted L 2008 Fetal goiter and bilateral ovarian cysts: A case report. Fetal Diagn Ther 23:132-135.
42. Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J 2009 Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 160:1-8.
43. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ 1999 Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549-555.
44. Man EB, Serunian SA 1976 Thyroid function in human pregnancy. IX. Development or retardation of 7-year-old progeny of hypothyroxinemic women. Am J Obstet Gynecol 125:949-957.
45. Zoeller RT, Rovet J 2004 Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 16:809-818.